FierceBiotechOriginal article
{"a":[{"_":"Takeda scraps another phase 2 celiac disease therapy, narrowing pipeline to one","$":{"href":"/biotech/takeda-scraps-another-phase-2-stage-celiac-disease-therapy-one-hope-left","hreflang":"en"}}]}
Phase 2negativeNegative
AI Analysis
Summary
Takeda has discontinued another phase 2 celiac disease therapy, leaving the company with only one remaining candidate in this therapeutic area.
Clinical Trial Data
Phase
2
Primary Endpoint
Not Met
Outcome Details
Phase 2 celiac disease therapy discontinued
Importance:5/10
Sentiment:
-0.70
pipeline_reductiondrug_discontinuationceliac_diseasephase_2
Related Companies
Read the original article
Published by FierceBiotech on July 30, 2026 7:28 AM
